Lisa Saiman

Active 1990–2024

128
Papers
19,730
Citations
83
h-index
125
i10-index

Citations

Citations per year for Lisa Saiman1978: 2 citations1985: 2 citations1989: 2 citations1990: 2 citations1991: 6 citations1992: 27 citations1993: 21 citations1994: 22 citations1995: 30 citations1996: 40 citations1997: 26 citations1998: 31 citations1999: 40 citations2000: 38 citations2001: 54 citations2002: 92 citations2003: 108 citations2004: 113 citations2005: 162 citations2006: 157 citations2007: 163 citations2008: 154 citations2009: 130 citations2010: 133 citations2011: 114 citations2012: 146 citations2013: 124 citations2014: 164 citations2015: 131 citations2016: 106 citations2017: 148 citations2018: 108 citations2019: 483 citations2020: 476 citations2021: 494 citations2022: 345 citations2023: 228 citations2024: 358 citations2025: 119 citations2026: 2 citations1979–1984: no citations, so these years are not shown1986–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,034 citing papers, 32.5% of this breakdownUnited Kingdom: 497 citing papers, 7.9% of this breakdownCanada: 320 citing papers, 5.1% of this breakdownItaly: 297 citing papers, 4.7% of this breakdownFrance: 272 citing papers, 4.4% of this breakdownGermany: 237 citing papers, 3.8% of this breakdownAustralia: 215 citing papers, 3.4% of this breakdownNetherlands: 184 citing papers, 2.9% of this breakdownChina: 173 citing papers, 2.8% of this breakdownSpain: 158 citing papers, 2.5% of this breakdownSwitzerland: 135 citing papers, 2.2% of this breakdownIndia: 118 citing papers, 1.9% of this breakdown
0%32.5%Other 25.9%

Fields

  • Medicine73.1%
  • Biochemistry, Genetics and Molecular Biology13.5%
  • Immunology and Microbiology4.8%
  • Health Professions3%
  • Nursing1.2%
  • Agricultural and Biological Sciences0.8%
  • Other3.6%

Topics

  • Cystic Fibrosis Research Advances7.3%
  • Bacterial biofilms and quorum sensing3.5%
  • Neonatal and Maternal Infections3.4%
  • Antifungal resistance and susceptibility3.4%
  • Antibiotic Resistance in Bacteria3.3%
  • Neonatal Respiratory Health Research2.6%
  • Other76.5%

Coauthors

All papers

Open in search
  1. Incidence of Respiratory Syncytial Virus Infection Among Hospitalized Adults, 2017-2020.

    Authors: , , , , , , , , , - Clinical Infectious Diseases 2021 cited by 245

  2. Strategies to prevent surgical site infections in acute-care hospitals: 2022 Update

    Authors: , , , , , , , , , , , , , - Infection Control and Hospital Epidemiology 2023 cited by 257

  3. Change in functional status associated with respiratory syncytial virus infection in hospitalized older adults

    Authors: , , , , , , , , - Influenza and Other Respiratory Viruses 2022 cited by 75

  4. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , - Thorax 2015 cited by 470

  5. Strategies to Prevent Surgical Site Infections in Acute Care Hospitals: 2014 Update

    Authors: , , , , , , , , , , - Infection Control and Hospital Epidemiology 2014 cited by 1,205

  6. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary

    Authors: , , , , , , , , , , , , , , , , , , , - Thorax 2015 cited by 460

  7. Azithromycin in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa

    Authors: , , , , , , , , , , - JAMA 2003 cited by 956

  8. Severe Clinical Outcomes Among Adults Hospitalized With Respiratory Syncytial Virus Infections, New York City, 2017-2019

    Authors: , , , , , , , , - Public Health Reports 2021 cited by 30

  9. Phase II studies of nebulised Arikace in CF patients withPseudomonas aeruginosainfection

    Authors: , , , , , , , , , , , , , , , , - Thorax 2013 cited by 219

  10. Cost determinants among adults hospitalized with respiratory syncytial virus in the United States, 2017–2019

    Authors: , , , , , , , , - Influenza and Other Respiratory Viruses 2021 cited by 45

  11. Infection Prevention and Control Guideline for Cystic Fibrosis: 2013 Update

    Authors: , , , , , , , , , , , , , , , , , , , , - Infection Control and Hospital Epidemiology 2014 cited by 385

  12. Epidemiology, clinical features, and resource utilization associated with respiratory syncytial virus in the community and hospital

    Authors: , , , , , , , , - Influenza and Other Respiratory Viruses 2020 cited by 51

  13. Risk factors for candidemia in Neonatal Intensive Care Unit patients

    Authors: , , , , , , , , , , , - The Pediatric Infectious Disease Journal 2000 cited by 590

  14. Time for a Neonatal-Specific Consensus Definition for Sepsis

    Authors: , , , , , - Pediatric Critical Care Medicine 2014 cited by 304

  15. The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial

    Authors: , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2022 cited by 38

  16. Comparative incidence and burden of respiratory viruses associated with hospitalization in adults in New York City

    Authors: , , , , , - Influenza and Other Respiratory Viruses 2021 cited by 24

  17. Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis

    Authors: , , , , , , - CHEST Journal 2015 cited by 233

  18. Pathogen Distribution and Antimicrobial Resistance Among Pediatric Healthcare-Associated Infections Reported to the National Healthcare Safety Network, 2011–2014

    Authors: , , , , , - Infection Control and Hospital Epidemiology 2017 cited by 161

  19. Clinical and socioeconomic burden of rhinoviruses/enteroviruses in the community

    Authors: , , , , , , - Influenza and Other Respiratory Viruses 2022 cited by 18

  20. Effect of Azithromycin on Pulmonary Function in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosaA Randomized Controlled Trial

    Authors: - JAMA 2010 cited by 331

  21. Antibiotic Resistance in Neonatal Intensive Care Unit Pathogens: Mechanisms, Clinical Impact, and Prevention Including Antibiotic Stewardship

    Authors: , - Clinics in Perinatology 2010 cited by 157

  22. Exploring the nurses' role in antibiotic stewardship: A multisite qualitative study of nurses and infection preventionists

    Authors: , , , , , , , - American Journal of Infection Control 2018 cited by 120

  23. Principles and Strategies of Antimicrobial Stewardship in the Neonatal Intensive Care Unit

    Authors: , - Seminars in Perinatology 2012 cited by 120

  24. Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung Infections

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giovanni Taccetti, Michael M. Tunney, Kevin Winthrop, Edith T. Zemanick - Clinical Infectious Diseases 2019 cited by 77